Memantine
Prescription Alzheimer's medicine that eases glutamate overload of nerve cells and modestly slows decline.
The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.
Pharmacology
Contents
DETAILED OVERVIEW
What is Memantine?
Memantine is a prescription medicine approved for moderate-to-severe Alzheimer's disease: by the US FDA in 2003, and by the European Medicines Agency (EMA) as well. Brand names include Namenda, Ebixa and Axura. It is not a controlled narcotic and is not on the anti-doping list.
Long-lasting, low-level overstimulation by glutamate, one of the brain's main excitatory messengers, can damage nerve cells. Memantine dampens this while letting through the strong, short signals needed for learning. In trials it modestly slowed the decline in thinking and daily functioning, but it does not reverse the disease; it is often given together with another Alzheimer's medicine such as donepezil. It is generally well tolerated, but may cause dizziness, headache or confusion. Caution is needed in severe kidney failure because the drug can build up, and its safety in pregnancy and breastfeeding is not established.
Mechanism
NMDA antagonist (uncompetitive, low-affinity)
Half-life
~60-100 hours
Legal status
Prescription drug (FDA/EMA approved)
In community reports memantine is usually not described as a classic, immediately noticeable nootropic: caregivers and patients more often mention a slower rate of decline and a calmer, less agitated daily life than a sudden boost in mental sharpness. Some report mild dizziness or headache in the early titration phase, which usually eases as the dose is raised gradually. The effect builds slowly over weeks, and the long half-life avoids the on-off swings familiar from stimulants.
⚠ Not clinical evidence – based on user accounts.
Receptor profile
- NMDA receptorsStrong
- Excess glutamate / excitotoxic calcium influxStrong
- 5-HT3 and α7 nicotinic acetylcholine receptorsWeak
- Dopamine (indirect)Weak
Safety
Side effects, stop signs, contraindications
Side effects · 6
- Dizziness
- Headache
- Confusion or cognitive slowing, especially at higher doses
- Constipation
- Somnolence, less often restlessness or agitation
- Occasional rise in blood pressure
Contraindications · 4
- Severe renal impairment: dose reduction required, risk of accumulation
- Pregnancy and breastfeeding: safety not established, use only if clearly needed
- History of seizures: use with caution
- Known hypersensitivity to memantine
Related Nootropics
Same therapeutic category
Studies
Related research and clinical findings
Memantine in moderate-to-severe Alzheimer's disease
Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Möbius HJ
Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial
Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonald S, Gergel I
Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial
Peskind ER, Potkin SG, Pomara N, Ott BR, Graham SM, Olin JT, McDonald S
The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer's disease taking cholinesterase inhibitors
Grossberg GT, Manes F, Allegri RF, et al.
Memantine for dementia
McShane R, Westby MJ, Roberts E, et al.
FAQ
FAQ
Memantine is a prescription drug approved for moderate-to-severe Alzheimer's disease. It calms down excessive activity of a brain chemical (glutamate) that can overstimulate and damage nerve cells, and this can modestly slow the decline in thinking and daily functioning. It's generally well tolerated and is often combined with other Alzheimer's medications like donepezil.
Telegram
Have a question about Memantine?
Reach out to us on Telegram for a personalized stack. We'll be happy to help.
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
Structure & chemistry
The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.
